American multinational medical technology company GE HealthCare and Singapore-based A*STAR's Institute of Mate...
The National University of Singapore (NUS) Yong Loo Lin School of Medicine (NUS Medicine) has received a gift ...
Cedars Sinai Intellectual Property Company (CSIP), the innovation arm of Cedars-Sinai Medical Centre and SEEDS Capital, ...
Singapore based startup CytoMed Therapeutics, spun off from the Agency for Science, Technology and Research (A*STAR), ha...
Singapore-based startup Lucence recently unveiled LucenceINSIGHT, its pioneering multi-cancer early detection (MCED) blo...
SomaLogic, Inc., a global leader in proteomics technology, has announced tis first grant in the APAC region by spon...
How do you determine the hazardous implications of surgical smoke and what are the current procedures in practice? ...
How is comprehensive genomic profiling (CGP) enhancing the quality of cancer management? Comprehensive genomic prof...
US-based startup ObvioHealth has announced a partnership with A*STAR's Singapore Institute for Clinical Scienc...
Albatroz Therapeutics, a Singapore-based biotechnology startup targeting tissue remodeling to stop cancer growth and t...
Scientists from A*STAR’s Genome Institute of Singapore (GIS) have ascertained that there is no stable microbial co...
Japan-based HOYA Vision Care, a leader in optical technology innovation, has launched MiYOSMART Sun spectacle lenses in ...
UK-based firm Plasticell, a developer of stem cell technologies and advanced therapies, has entered into a strategic col...
Wellcome Leap (in the US) and Temasek Trust (in Singapore) have partnered to launch a $60 million Dynamic Resi...
The results from a new YouGov survey called, ‘What’s Next for COVID-19 in Singapore?’, commissioned by...
Illumina Singapore, subsidiary of US-based biotech firm Illumina Inc, has announced an inaugural partnership with the&nb...
LifeStrands Genomics, a subsidiary of the Pathology Asia group in Singapore, and Ambry Genetics, a subsid...
Swiss firm Zühlke Group has announced the appointment of Jim Lim as Head of Market Unit (Health & Medtech)...
